David M. Walentiny, Ph.D.
Affiliations: | Psychology | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Behavioral PharmacologyGoogle:
"David Walentiny"Mean distance: 17.45 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentor| Jenny L. Wiley | grad student | 2011 | VCU | |
| (Discriminative stimulus properties of 3-substituent rimonabant analogs.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zheng Y, Obeng S, Reinecke BA, et al. (2019) Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder. European Journal of Pharmacology. 172812 |
| Walentiny DM, Moisa LT, Beardsley PM. (2019) Oxycodone-Like Discriminative Stimulus Effects of Fentanyl-Related Emerging Drugs of Abuse in Mice. Neuropharmacology |
| Walentiny DM, Wiebelhaus JM, Beardsley PM. (2018) Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice. Drug and Alcohol Dependence. 187: 335-342 |
| Wiebelhaus JM, Walentiny DM, Beardsley PM. (2015) Effects of acute and repeated administration of oxycodone and naloxone-precipitated withdrawal on Intracranial Self-Stimulation (ICSS) in rats. The Journal of Pharmacology and Experimental Therapeutics |
| Walentiny DM, Vann RE, Wiley JL. (2015) Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. Neuropharmacology. 93: 237-42 |
| Wiley JL, Walentiny DM, Wright MJ, et al. (2014) Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. European Journal of Pharmacology. 737: 97-105 |
| Ignatowska-Jankowska BM, Ghosh S, Crowe MS, et al. (2014) In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. British Journal of Pharmacology. 171: 1392-407 |
| Walentiny D, Vann R, Mahadevan A, et al. (2013) Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice. British Journal of Pharmacology. 169: 10-20 |
| Tobey KM, Walentiny DM, Wiley JL, et al. (2012) Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice. Psychopharmacology. 223: 159-68 |
| Vann RE, Walentiny DM, Burston JJ, et al. (2012) Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride. Neuropharmacology. 62: 1019-27 |